Preferentially Expressed Antigen in Melanoma (PRAME) Expression in Malignant, but Not Benign, Peripheral Nerve Sheath Tumors

J Neuropathol Exp Neurol. 2021 Mar 22;80(4):384-386. doi: 10.1093/jnen/nlaa125.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antigens, Neoplasm / biosynthesis*
  • Antigens, Neoplasm / genetics
  • Gene Expression Regulation, Neoplastic*
  • Humans
  • Nerve Sheath Neoplasms / genetics
  • Nerve Sheath Neoplasms / metabolism*
  • Nerve Sheath Neoplasms / pathology
  • Neurilemmoma / genetics
  • Neurilemmoma / metabolism*
  • Neurilemmoma / pathology
  • Neurofibroma / genetics
  • Neurofibroma / metabolism*
  • Neurofibroma / pathology
  • Survival Rate / trends

Substances

  • Antigens, Neoplasm
  • PRAME protein, human